These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 58199)
1. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Sagar S; Nairn D; Stamatakis JD; Maffei FH; Higgins AF; Thomas DP; Kakkar VV Lancet; 1976 May; 1(7970):1151-4. PubMed ID: 58199 [TBL] [Abstract][Full Text] [Related]
2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
3. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet; 1975 Jul; 2(7924):45-51. PubMed ID: 49649 [TBL] [Abstract][Full Text] [Related]
4. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673 [TBL] [Abstract][Full Text] [Related]
5. Heparin and dihydroergotamine prophylaxis against thrombo-embolism after hip arthroplasty. Kakkar VV; Fok PJ; Murray WJ; Paes T; Merenstein D; Dodds R; Farrell R; Crellin RQ; Thomas EM; Morley TR J Bone Joint Surg Br; 1985 Aug; 67(4):538-42. PubMed ID: 4030846 [TBL] [Abstract][Full Text] [Related]
6. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group. Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065 [TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis. Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367 [TBL] [Abstract][Full Text] [Related]
8. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery. Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of postoperative thrombo-embolism by heparin/dihydroergotamine (author's transl]. Koppenhagen K; Wiechmann A; Frey E; Wenig HG; Latka H; Zühlke HV; Tank E; Hardieck J; Ernst H; Häring R Dtsch Med Wochenschr; 1977 Sep; 102(39):1374-8. PubMed ID: 334500 [TBL] [Abstract][Full Text] [Related]
10. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery]. Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998 [TBL] [Abstract][Full Text] [Related]
11. On thrombo-embolism after total hip replacement in epidural analgesia: a controlled study of dextran 70 and low-dose heparin combined with dihydroergotamine. Fredin HO; Rosberg B; Arborelius M; Nylander G Br J Surg; 1984 Jan; 71(1):58-60. PubMed ID: 6689974 [TBL] [Abstract][Full Text] [Related]
12. [Low-dose heparin and acetyl-salicylic acid after elective operations on the hip joint (author's transl)]. Schöndorf TH; Weber U; Lasch HG Dtsch Med Wochenschr; 1977 Sep; 102(37):1314-8. PubMed ID: 902597 [TBL] [Abstract][Full Text] [Related]
13. [The case for more active prevention of deep-vein thrombosis after major surgery (author's transl)]. Hubens A; Peeters R Acta Chir Belg; 1976 Jul; 75(4):402-15. PubMed ID: 797205 [TBL] [Abstract][Full Text] [Related]
14. Low-dose heparin and deep-vein thrombosis after total hip replacement. Mannucci PM; Citterio LE; Panajotopoulos N Thromb Haemost; 1976 Aug; 36(1):157-64. PubMed ID: 1036806 [TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery. Lahnborg G Acta Chir Scand; 1980; 146(5):319-22. PubMed ID: 7468062 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine. Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493 [TBL] [Abstract][Full Text] [Related]
17. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Morris GK; Henry AP; Preston BJ Lancet; 1974 Oct; 2(7884):797-800. PubMed ID: 4138248 [No Abstract] [Full Text] [Related]
18. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin. Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement. Barber HM; Feil EJ; Galasko CS; Edwards DH; Sutton RA; Haynes DW; Bentley G Postgrad Med J; 1977 Mar; 53(617):130-3. PubMed ID: 859784 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement. Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]